Skip to main content
Watch Insiders
XERSHealthcare

Xeris Biopharma Holdings Inc (XERS) Insider Trading

In the last 90 days, 3 Xeris Biopharma Holdings Inc (XERS) insiders reported no open-market purchases and 10 sales totaling $1,202,484. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 1, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 1, 2026Steven PieperSee RemarksSale5,000$9.41$47,037
Oct 1, 2026Kevin McCullochSee RemarksSale15,000$9.41$141,120
Oct 1, 2026Beth HechtSee RemarksSale16,666$9.41$156,792
Sep 28, 2026Kevin McCullochSee RemarksSale25,000$10.00$250,000
Sep 1, 2026Kevin McCullochSee RemarksSale15,000$8.49$127,308
Sep 1, 2026Steven PieperSee RemarksSale5,000$8.50$42,500
Sep 1, 2026Beth HechtSee RemarksSale16,666$8.49$141,434
Aug 12, 2026Steven PieperSee RemarksSale5,000$8.50$42,500
Aug 3, 2026Kevin McCullochSee RemarksSale15,000$8.02$120,240
Aug 3, 2026Beth HechtSee RemarksSale16,666$8.01$133,553
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

XERS insider trading FAQ

Are XERS insiders buying or selling?
Over the last 90 days, XERS insiders were net sellers, reporting $0.00 of open-market purchases and $1,202,484 of sales.
When was the last XERS insider purchase?
No open-market insider purchase of Xeris Biopharma Holdings Inc stock was reported in the last 90 days.
Where does XERS insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Xeris Biopharma Holdings Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.